Related Experiment Videos
[Expression of proto-oncogene bcl-2 in squamous cell carcinoma of the larynx]
Abstract:
Apoptosis, or programmed cell death, is responsible for deleting cells in normal tissues to maintain homeostasis after DNA damage. Apoptosis has several physiological inhibitors, one of the most important being the proto-oncogene bcl-2. An immunohistochemical study was made of bcl-2 expression in 25 squamous cell carcinomas of the larynx, in laryngeal mucosa distant from the primary neoplasm, and in lymph node metastases. The relationship between bcl-2 expression and various clinical and pathological parameters was investigated. Bcl-2 was detected in 40% of primary tumors and in 71% of lymph node metastases; it seems to be a late event in laryngeal malignant transformation. We found no statistical association between bcl-2 expression and most of the clinical and pathological parameters examined. Only tumor differentiation was related to bcl-2 expression, bcl-2 positive tumors being moderately or poorly differentiated (p < 0.02).
Insights
Bcl-2, a programmed cell death inhibitor, was found in 40% of laryngeal squamous cell carcinomas and 71% of metastases. Bcl-2 expression correlated with poorer tumor differentiation, suggesting a role in late-stage laryngeal cancer progression.
Area of Science:
- Oncology
- Cell Biology
- Molecular Pathology
Background:
- Apoptosis, or programmed cell death, is crucial for tissue homeostasis and is regulated by inhibitors like the proto-oncogene bcl-2.
- Dysregulation of apoptosis is implicated in cancer development, making its inhibitors key areas of research.
Purpose of the Study:
- To investigate bcl-2 expression in laryngeal squamous cell carcinoma (LSCC) and its relationship with clinical and pathological parameters.
- To determine if bcl-2 expression is associated with tumor stage or differentiation in LSCC.
Main Methods:
- Immunohistochemical analysis of bcl-2 expression in 25 LSCC primary tumors, adjacent laryngeal mucosa, and lymph node metastases.
- Correlation analysis between bcl-2 expression and clinicopathological features such as tumor differentiation, invasion, and metastasis.
Main Results:
- Bcl-2 was detected in 40% of primary LSCCs and 71% of lymph node metastases.
- Bcl-2 expression showed a significant association with poorer tumor differentiation (p < 0.02), with positive staining in moderately or poorly differentiated tumors.
- No significant association was found between bcl-2 expression and other examined clinical or pathological parameters.
Conclusions:
- Bcl-2 expression appears to be a late event in the malignant transformation of the larynx.
- The correlation between bcl-2 positivity and poor differentiation suggests its potential role in the progression of LSCC.
- Further research is warranted to elucidate the precise role of bcl-2 in laryngeal carcinogenesis and its implications for prognosis.